文献速递先天性心脏病外科瓣膜外科

英国与爱尔兰成人及青少年先天性心脏病肺动脉瓣置换术调查

Pulmonary Valve Replacement in Adults and Adolescents With Congenital Heart Disease: A United Kingdom and Ireland Survey.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

该调查面向英国和爱尔兰成人先天性心脏病中心的全体顾问级先天性心脏外科医生发放在线问卷,了解肺动脉瓣置换术中人工瓣膜选择、决策因素、植入技术、术后抗凝及青少年实践差异与随机化意愿。27名(69%)医生回复,19人(70%)偏好Edwards牛心包瓣,仅2人(7%)偏好Hancock II瓣,6人(22%)偏好肺动脉同种移植物;长期免于再干预数据(23人,85%)是瓣膜选择最重要因素。22人(81%)愿在临床试验中将成人患者随机分配至牛心包瓣或猪异种瓣,青少年患者随机化意愿降至11人(41%)。

要点

  • 多数回复医生偏好Edwards牛心包瓣(19人,70%),瓣膜选择存在异质性。
  • 长期免于再干预数据是瓣膜选择最重要因素(23人,85%)。
  • 81%医生愿在试验中随机化成人患者,青少年降至41%。

核心结论

  • 调查显示肺动脉瓣人工瓣膜选择存在异质性,结合缺乏临床试验证据,支持临床均势存在。
  • 多数医生愿意改变实践,提示比较牛心包瓣与猪异种瓣的实用性多中心随机对照试验在成人中可行。

研究设计与样本

  • 向英国和爱尔兰成人先天性心脏病中心全体顾问级先天性心脏外科医生发放在线调查问卷。
  • 共获得27名(69%)外科医生回复。
  • 调查内容包括偏好瓣膜、决策影响因素、植入技术、术后抗凝、青少年实践差异及试验随机化意愿。

主要发现

  • 19名(70%)偏好Edwards牛心包瓣,其中最常用Inspiris Resilia(7名,26%)。
  • 仅2名(7%)偏好Hancock II瓣,其余6名(22%)偏好肺动脉同种移植物。
  • 长期免于再干预数据(23名,85%)是影响瓣膜选择的最重要因素。
  • 22名(81%)愿在临床试验中将成人患者随机分配至牛心包瓣或猪异种瓣,Perimount Magna Ease与Hancock II分别为最可接受者。
  • 青少年患者随机化意愿降至11名(41%)。

关键数值与推荐

  • 偏好Edwards牛心包瓣:19/27(70%);Inspiris Resilia:7/27(26%)。
  • 偏好Hancock II瓣:2/27(7%);偏好肺动脉同种移植物:6/27(22%)。
  • 长期免于再干预数据为最重要决策因素:23/27(85%)。
  • 成人随机化意愿:22/27(81%);青少年随机化意愿:11/27(41%)。

临床怎么用

  • 调查结果提示成人先天性心脏病肺动脉瓣置换的瓣膜选择尚无统一标准,存在临床均势。
  • 多数医生愿参与比较牛心包瓣与猪异种瓣的随机试验,可支持设计实用性多中心随机对照试验。
  • 青少年患者随机化意愿较低,相关试验设计需考虑这一实践差异。

局限性

  • 回复率为69%(27名),未覆盖全部目标人群。
  • 为问卷调查,反映医生偏好与实践意愿,非临床结局证据。
  • 未提供 randomized 试验数据或长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Many models of bioprosthesis are available for pulmonary valve replacement in adults with congenital heart disease, but there is a lack of randomized evidence to guide practice. We surveyed congenital cardiac surgeons to establish current practice and willingness to change within a clinical trial. METHODS: An online survey was sent to all consultant congenital cardiac surgeons in adult congenital centres in the United Kingdom and Ireland. Information was sought on preferred prostheses, factors influencing decision-making, implant technique, postoperative anticoagulation, practice variations in adolescents, and willingness to randomize patients to different prostheses within a trial. RESULTS: Responses were obtained from 27 (69%) surgeons. A total of 19 (70%) preferred an Edwards bovine pericardial valve, most commonly the Inspiris Resilia (7, 26%). Only 2 (7%) favoured the Hancock II valve; the remaining 6 (22%) preferred pulmonary homografts. Data regarding long-term freedom from reintervention (23, 85%) was the most important factor influencing prosthesis choice. A total of 22 (81%) surgeons were willing to randomize adult patients to either a bovine pericardial valve or a porcine xenograft in a clinical trial, with Perimount Magna Ease and Hancock II being the most acceptable, respectively. Willingness to randomize dropped to 11 (41%) surgeons for adolescent patients. CONCLUSIONS: This survey demonstrates heterogeneity in the choice of pulmonary valve prosthesis. Combined with a lack of evidence from clinical trials, our findings support the presence of clinical equipoise. Most surgeons are willing to change practice, suggesting that a pragmatic, multicentre, randomized controlled trial comparing bovine pericardial versus porcine xenograft for pulmonary valve replacement in adults is feasible.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Bond CJ, Jones TJ, Hoschtitzky JA, et al. Pulmonary Valve Replacement in Adults and Adolescents With Congenital Heart Disease: A United Kingdom and Ireland Survey. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40991337. doi:10.1093/icvts/ivaf214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。